Terrie Curran - Net Worth and Insider Trading
Terrie Curran Net Worth
The estimated net worth of Terrie Curran is at least $4 Million dollars as of 2025-07-24. Terrie Curran is the President and Chief Executive of Phathom Pharmaceuticals Inc and owns about 364,305 shares of Phathom Pharmaceuticals Inc (PHAT) stock worth over $3 Million. Terrie Curran is the SEE REMARKS of Celgene Corp and owns about 3,081 shares of Celgene Corp (CELG) stock worth over $333,487. Terrie Curran is also the Director of Arcutis Biotherapeutics Inc and owns about 10,139 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $151,172. Besides these, Terrie Curran also holds Myovant Sciences Ltd (MYOV) . Details can be seen in Terrie Curran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Terrie Curran has not made any transactions after 2025-01-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Terrie Curran
Terrie Curran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terrie Curran owns 3 companies in total, including Myovant Sciences Ltd (MYOV) , Phathom Pharmaceuticals Inc (PHAT) , and Arcutis Biotherapeutics Inc (ARQT) .
Click here to see the complete history of Terrie Curran’s form 4 insider trades.
Insider Ownership Summary of Terrie Curran
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2021-09-09 | director |
| PHAT | Phathom Pharmaceuticals Inc | 2025-01-21 | director |
| ARQT | Arcutis Biotherapeutics Inc | 2024-11-11 | director |
Terrie Curran Latest Holdings Summary
Terrie Curran currently owns a total of 4 stocks. Among these stocks, Terrie Curran owns 364,305 shares of Phathom Pharmaceuticals Inc (PHAT) as of January 21, 2025, with a value of $3 Million and a weighting of 86.56%. Terrie Curran owns 3,081 shares of Celgene Corp (CELG) as of September 18, 2019, with a value of $333,487 and a weighting of 9.25%. Terrie Curran also owns 10,139 shares of Arcutis Biotherapeutics Inc (ARQT) as of November 11, 2024, with a value of $151,172 and a weighting of 4.19%. The other 1 stocks Myovant Sciences Ltd (MYOV) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Terrie Curran
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals Inc | 2025-01-21 | 364,305 | 8.57 | 3,122,094 |
| CELG | Celgene Corp | 2019-09-18 | 3,081 | 108.24 | 333,487 |
| ARQT | Arcutis Biotherapeutics Inc | 2024-11-11 | 10,139 | 14.91 | 151,172 |
| MYOV | Myovant Sciences Ltd | 2021-09-09 | 0 | 26.98 | 0 |
Holding Weightings of Terrie Curran
Terrie Curran Form 4 Trading Tracker
According to the SEC Form 4 filings, Terrie Curran has made a total of 9 transactions in Phathom Pharmaceuticals Inc (PHAT) over the past 5 years, including 2 buys and 7 sells. The most-recent trade in Phathom Pharmaceuticals Inc is the sale of 19,109 shares on January 21, 2025, which brought Terrie Curran around $125,928.
According to the SEC Form 4 filings, Terrie Curran has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 11,338 shares on September 18, 2019, which brought Terrie Curran around $1 Million.
According to the SEC Form 4 filings, Terrie Curran has made a total of 1 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 8,687 shares on November 11, 2024, which brought Terrie Curran around $94,254.
More details on Terrie Curran's insider transactions can be found in the Insider Trading History of Terrie Curran table.Insider Trading History of Terrie Curran
- 1
Terrie Curran Trading Performance
GuruFocus tracks the stock performance after each of Terrie Curran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terrie Curran is 56.13%. GuruFocus also compares Terrie Curran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terrie Curran within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terrie Curran's insider trading performs compared to the benchmark.
Performance of Terrie Curran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.44 | | | | | |
| Relative Return to S&P 500(%) | 23.47 | | | | | |
Terrie Curran Ownership Network
Ownership Network List of Terrie Curran
Ownership Network Relation of Terrie Curran
Terrie Curran Owned Company Details
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Terrie Curran is the director of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
Terrie Curran Mailing Address
Above is the net worth, insider trading, and ownership report for Terrie Curran. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Terrie Curran's mailing address is: New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
